Are We Closer to a Cure with Perioperative Immunotherapy in Early-Stage Resectable NSCLC? Current Conclusions and Ongoing Questions in Clinical Care
- Provider:PVI, PeerView Institute for Medical Education
- Activity Link: https://www.peerview.com/AWU
- Start Date: 2024-09-24 05:00:00
- End Date: 2024-09-24 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
- Commercial Support: Source: Merck (Any division) - Amount: 100000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest